Addressing the Unmet Need in Cardiovascular Disease Development

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
While the impact of cardiovascular disease remains a major cause of mortally and morbidity, not only in developed countries but also in developing countries, the investment in research and development is at record low with cardiovascular compounds being less than one percent of drugs in development. This panel will explore strategies to develop cardiovascular treatments in a rare disease focused world.
Moderator
photo
CEO
Anthos Therapeutics Inc
Speakers
photo
Director, Digital Health
MyoKardia, Inc.
photo
President & Chief Executive Officer
Perosphere Technologies
photo
CEO
Anthos Therapeutics Inc
photo
Director, Strategic Partnerships
Evidation Health, Inc.
photo
Associate Physician, Department of Cardiology
Brigham and Women’s Hospital